UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Motor neurone disease: progress and challenges

Medical journal of Australia, 2017-05, Vol.206 (8), p.357-362

2017

Volltextzugriff (PDF)

INCITE: A randomised trial comparing constraint induced movement therapy and bimanual training in children with congenital hemiplegia

BMC neurology, 2010-01, Vol.10 (1), p.4-4, Article 4

2010

Volltextzugriff (PDF)

054 Disability improvement is observed in each functional system in alemtuzumab-treated patients with active RRMS: results from CARE-MS II extension

Journal of neurology, neurosurgery and psychiatry, 2018-06, Vol.89 (6), p.A22-A22

2018

Volltextzugriff (PDF)

Equivalent Retention of Gains at 1 Year After Training With Constraint-Induced or Bimanual Therapy in Children With Unilateral Cerebral Palsy

Neurorehabilitation and neural repair, 2011-09, Vol.25 (7), p.664-671

2011

Volltextzugriff (PDF)

Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy – Part 1

Journal of clinical neuroscience, 2009-03, Vol.16 (3), p.355-365

2009

Volltextzugriff (PDF)

Can changes in cortical excitability distinguish progressive from juvenile myoclonic epilepsy?

Epilepsia (Copenhagen), 2010-10, Vol.51 (10), p.2084-2088

2010

Volltextzugriff (PDF)

Cortical excitability decreases in Lennox-Gastaut syndrome

Epilepsia (Copenhagen), 2012-09, Vol.53 (9), p.1546-1553

2012

Volltextzugriff (PDF)

Disability Improvement Is Observed in Each Functional System in Alemtuzumab-Treated Patients With Active RRMS: Results From CARE-MS II Extension (P6.364)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Incidence of Stroke Subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): Differences between Men and Women

Neuroepidemiology, 2009-01, Vol.32 (1), p.11-18

2009

Volltextzugriff (PDF)

Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy - Part 2

Journal of clinical neuroscience, 2009-04, Vol.16 (4), p.485-500

2009

Volltextzugriff (PDF)

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy

Journal of clinical neuroscience, 2014-11, Vol.21 (11), p.1847-1856

2014

Volltextzugriff (PDF)

Number Needed to Treat Analyses to Assess Clinical Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Alemtuzumab or Ocrelizumab (P6.384)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

A new era in the treatment of multiple sclerosis

Medical journal of Australia, 2015-08, Vol.203 (3), p.139-141

2015

Volltextzugriff (PDF)

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies

Journal of clinical neuroscience, 2014-11, Vol.21 (11), p.1835-1846

2014

Volltextzugriff (PDF)

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations

Journal of clinical neuroscience, 2014-11, Vol.21 (11), p.1857-1865

2014

Volltextzugriff (PDF)

Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit?

Cerebrovascular diseases (Basel, Switzerland), 2005-01, Vol.20 (4), p.239-244

2005

Volltextzugriff (PDF)

Improvements Across Functional Systems Are Maintained Regardless of Early VS Late Confirmed Disability Improvement: CARE-MS 6-Year Follow-Up

Multiple sclerosis and related disorders, 2020-01, Vol.37, p.101587, Article 101587

2020

Volltextzugriff (PDF)

Efficacy of a Fourth Alemtuzumab Course in RRMS Patients from CARE-MS II Who Experienced Disease Activity After Three Prior Courses

Multiple sclerosis and related disorders, 2020-01, Vol.37, p.101585, Article 101585

2020

Volltextzugriff (PDF)

Bilateral facial nerve palsies secondary to chronic inflammatory demyelinating polyneuropathy following adalimumab treatment

Clinical neurology and neurosurgery, 2018-01, Vol.164, p.64-66

2018

Volltextzugriff (PDF)

Handicap 5 Years after Stroke in the North East Melbourne Stroke Incidence Study

Cerebrovascular diseases (Basel, Switzerland), 2009-02, Vol.27 (2), p.123-130

2009

Volltextzugriff (PDF)

Intracortical Hyperexcitability in Humans with a GABA sub(A) Receptor Mutation

Cerebral cortex (New York, N.Y. 1991), 2008-03, Vol.18 (3), p.664-669

2008

Volltextzugriff (PDF)

COMBIT: protocol of a randomised comparison trial of COMbined modified constraint induced movement therapy and bimanual intensive training with distributed model of standard upper limb rehabilitation in children with congenital hemiplegia

BMC neurology, 2013-06, Vol.13 (1), p.68-68, Article 68

2013

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Clinical Neurology
(28)
Neurosciences & Neurology
(28)
Humans
(24)
Female
(16)
Multiple Sclerosis
(15)
Neurosciences
(15)
Male
(13)
Adult
(10)
Neurology
(10)
Middle Aged
(7)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(7)
Follow-Up Studies
(6)
Multiple Sclerosis - Drug Therapy
(6)
Adolescent
(5)
Immunotherapy
(5)
Monoclonal Antibodies
(5)
Registries
(5)
Treatment Outcome
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies

Motor neurone disease: progress and challenges

INCITE: A randomised trial comparing constraint induced movement therapy and bimanual training in children with congenital hemiplegia

054 Disability improvement is observed in each functional system in alemtuzumab-treated patients with active RRMS: results from CARE-MS II extension

Equivalent Retention of Gains at 1 Year After Training With Constraint-Induced or Bimanual Therapy in Children With Unilateral Cerebral Palsy

Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy – Part 1

Can changes in cortical excitability distinguish progressive from juvenile myoclonic epilepsy?

Cortical excitability decreases in Lennox-Gastaut syndrome

Efficacy of Alemtuzumab in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Received Retreatment Due to Disease Activity After the Initial Two Courses: Results From the CARE-MS I Extension (P6.362)

Disability Improvement Is Observed in Each Functional System in Alemtuzumab-Treated Patients With Active RRMS: Results From CARE-MS II Extension (P6.364)

Efficacy of Alemtuzumab in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Received Retreatment Due to Disease Activity After the Initial Two Courses: Results From the CARE-MS II Extension (P6.363)

Incidence of Stroke Subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): Differences between Men and Women

Cortical hyperexcitability and epileptogenesis: Understanding the mechanisms of epilepsy - Part 2

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy

Number Needed to Treat Analyses to Assess Clinical Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Alemtuzumab or Ocrelizumab (P6.384)

A new era in the treatment of multiple sclerosis

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations

Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit?

Improvements Across Functional Systems Are Maintained Regardless of Early VS Late Confirmed Disability Improvement: CARE-MS 6-Year Follow-Up

Efficacy of a Fourth Alemtuzumab Course in RRMS Patients from CARE-MS II Who Experienced Disease Activity After Three Prior Courses

Bilateral facial nerve palsies secondary to chronic inflammatory demyelinating polyneuropathy following adalimumab treatment

Handicap 5 Years after Stroke in the North East Melbourne Stroke Incidence Study

Intracortical Hyperexcitability in Humans with a GABA sub(A) Receptor Mutation

COMBIT: protocol of a randomised comparison trial of COMbined modified constraint induced movement therapy and bimanual intensive training with distributed model of standard upper limb rehabilitation in children with congenital hemiplegia

Suchergebnisse filtern